Research Assistant Professor - Radiochemistry

University of Pennsylvania Perelman School of Medicine; Philadelphia (Philadelphia County); On-site; USD 120,000 - 180,000; Full time

Job summary

University of Pennsylvania Perelman School of Medicine in Radiology seeks candidates for an Assistant Professor on the non-tenure research track, focusing on radiopharmaceutical sciences with emphasis on radiochemistry, molecular imaging, and targeted radionuclide therapy.

The successful candidate will pursue an independent, externally funded program, collaborate across biomedical disciplines, and contribute to education and mentorship within the department.

Qualifications

• The candidate holds a Ph.D. or equivalent in radiopharmaceutical sciences, radiochemistry, molecular imaging, or a related field.
• Postdoctoral or other relevant research experience is preferred (0–3 years).
• Evidence of research productivity via peer-reviewed publications is expected.
• Ability to develop an independent, externally funded research program is desired.

Responsibilities

• Develop and lead an independent radiopharmaceutical research program with external funding.
• Engage in radiopharmaceutical design, synthesis, preclinical imaging, and translational studies.
• Publish findings in peer-reviewed journals and present at conferences.
• Mentor graduate students, postdocs, and collaborate across departments.

Skills

Radiopharmaceuticals

Radiochemistry

Molecular imaging

Radionuclide therapy

Education

Ph.D. or equivalent degree

Job description

University of Pennsylvania: Perelman School of Medicine: Perelman School of Medicine - Radiology

Location

Philadelphia, PA

Open Date

Nov 05, 2026

Deadline

Nov 05, 2028 at 11:59 PM Eastern Time

Description

The Department of Radiology at the Perelman School of Medicine at the University of Pennsylvania seeks candidates for an Assistant Professor position in the non-tenure research track. Expertise is required in the specific area of radiopharmaceutical sciences, with an emphasis on radiochemistry, molecular imaging, and/or targeted radionuclide therapy. Candidates should have experience in the development and evaluation of diagnostic or therapeutic radiopharmaceuticals, including relevant chemical, biological, or translational approaches. Preferred qualifications include postdoctoral or other relevant research experience, typically 0–3 years, in radiopharmaceutical sciences, radiochemistry, molecular imaging, or a related field. Candidates should demonstrate evidence of research productivity through peer-reviewed publications and potential to develop an independent, externally funded research program. Experience with radiopharmaceutical development, preclinical imaging, targeted alpha or beta therapies, or translational research is desirable. Applicants must have a Ph.D. or equivalent degree.

Research or scholarship responsibilities may include developing an innovative research program focused on the discovery, development, and translation of radiopharmaceuticals for imaging and therapy. Areas of particular interest include radiometal chemistry, radiolabeling methodologies, targeted radionuclide therapy, and the development of novel radiopharmaceutical agents for cancer and other diseases. Research activities may include radiopharmaceutical design and synthesis, preclinical imaging and therapy studies, pharmacokinetic and biodistribution evaluations, dosimetry, and translational studies supporting clinical development.

The successful candidate will be expected to pursue extramural research funding, contribute to scholarly publications, and establish collaborative research relationships across radiology, nuclear medicine, oncology, chemistry, engineering, and other biomedical disciplines. The candidate will also participate in the academic mission of the Department through mentorship, graduate and postgraduate training, and relevant professional service.

The position offers the opportunity to develop an independent research program within a multidisciplinary environment with established capabilities in radiochemistry, molecular imaging, and translational radiopharmaceutical development, including targeted radionuclide therapy.